Clinical benefits of Bifidobacterium infantis YLGB-1496 in modulating gut microbiota and immunity in young children.
- 2026-01-05
- Clinical Trial
- Frontiers in nutrition 12
- Mageswaran Uma Mageswary
- Pin Li
- Rocky Vester Richmond
- Yusof Azianey
- Intan Juliana Abd Hamid
- Fahisham Taib
- Min-Tze Liong
- Adli Ali
- Joo Shun Tan
- Yumei Zhang
- PubMed: 41561177
- DOI: 10.3389/fnut.2025.1713135
- Moderate evidence
the probiotic did not induce major restructuring but provided ecological stability, preventing the and preserving beneficial SCFA producing genera that declined in the placebo group (p < 0.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes